UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in AMPH — Amphastar Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in AMPH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,084,793
-$394,318 QoQ
Shares Held
55,375
+0.3% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52.933634311512414.ToString("F0")%
Shared 0.ToString("F0")%
None 47.06636568848758.ToString("F0")%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. AMPH ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,398,351 | $519,929,066 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
207,309 | $122,930,085 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
571,719 | $75,318,257 | |
| 4 | VTRS |
Viatris Inc
|
3,964,630 | $53,562,146 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
486,498 | $36,900,870 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,526,922 | $36,539,240 | |
| 7 | ALKS |
Alkermes plc.
|
403,153 | $14,255,486 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
443,527 | $9,207,616 |
All Filings in AMPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,084,793 | 55,375 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,479,111 | 55,232 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,448,025 | 54,335 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,150,249 | 93,652 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,292,787 | 79,089 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,090,366 | 83,231 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,709,873 | 76,445 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,432,120 | 85,803 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,924,836 | 43,836 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,801,308 | 45,292 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,148,512 | 46,717 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,244,258 | 39,051 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,464,410 | 39,051 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,235,316 | 44,087 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,304,484 | 46,423 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,665,916 | 47,885 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,552,099 | 43,234 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $792,231 | 34,016 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $646,641 | 34,016 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $883,228 | 43,811 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $752,712 | 41,087 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $826,257 | 41,087 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $770,380 | 41,087 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $843,304 | 37,547 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $655,467 | 44,169 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||